Isolation of antibiotic-resistant gram-negative organisms from donor respiratory culture does not impact non-lung solid organ recipient management

Clin Transplant. 2019 Aug;33(8):e13646. doi: 10.1111/ctr.13646. Epub 2019 Jul 28.

Abstract

Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) gram-negative bacteria may be transmitted from organ donors to solid organ transplant recipients and are associated with poor outcomes post-transplant.

Methods: We reported the prevalence of MDR/XDR gram-negative respiratory colonization among 702 deceased organ donors in the New York City area from 2011 to 2014 and performed chart reviews for a subset of recipients to determine whether donor respiratory culture results were predictive of subsequent recipient infection or used to guide post-transplant antimicrobial therapy.

Results: Fifty donors (7% of the cohort) had MDR or XDR gram-negative bacteria isolated from endotracheal aspirate or bronchoalveolar lavage culture. Organs from these 50 donors were transplanted into 120 recipients; chart review was performed for 89 of these recipients (38 kidney, 32 liver, 11 heart, 6 kidney/pancreas, 1 liver/kidney, 1 lung). None of the 89 recipients of organs from donors with MDR/XDR gram-negative respiratory colonization were reported to have a donor-derived infection post-transplant, and chart review for the 88 non-lung recipients indicated that peri-transplant antibiotics were not adjusted specifically for donor respiratory culture results.

Conclusion: These results suggest that donor respiratory culture results are not predictive of post-transplant infection in non-lung recipients and are unlikely to impact post-transplant management.

Keywords: antibiotic prophylaxis; antimicrobial resistance; donor-derived infections.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Disease Management
  • Drug Resistance, Multiple, Bacterial*
  • Follow-Up Studies
  • Graft Survival
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology
  • Gram-Negative Bacterial Infections / transmission*
  • Humans
  • Organ Transplantation / methods*
  • Prognosis
  • Respiratory System / drug effects
  • Respiratory System / microbiology*
  • Retrospective Studies
  • Tissue Donors / supply & distribution*
  • Transplant Recipients / statistics & numerical data*

Substances

  • Anti-Bacterial Agents